New credential being established for pharmaceutical professionals
and expertise required by professionals involved in drug product
development and manufacturing. The results will form a basis for a
new global credentialing program to raise professional standards
within the industry.
The study is being undertaken by the >Professional Certification Commission (PCC), a governing body of the >International Society for Pharmaceutical Engineering (ISPE), in conjunction with the >Professional Examination Service (PES), a not-for-profit organization that assists in creating and implementing credentials programs.
This international job analysis study began in October 2005 and has been receiving input from a broad range of stakeholders and experts. The results will be validated in early January 2006 through a Web-based survey distributed to up to 1,200 professionals worldwide.
The results of the study will then be used to develop key components of a program being developed by the International Society for Pharmaceutical Engineering (ISPE) to create a new pharmaceutical industry credential, the Chartered Pharmaceutical Professional (ChPP).
"The job analysis is the most critical step in developing a new industry credential," said Jerry Roth, ISPE's Director of Professional Certification.
Recipients of the new credential will have broad industry awareness of the objectives and methods in the areas of drug development, facilities and equipment, information and data management and control, supply chain economics, production systems, regulatory compliance, and quality assurance.
The purpose of the certification is to establish standards of competency for pharmaceutical industry professionals, assess their knowledge and skills, encourage growth and innovation in the pharmaceutical industry, and formally recognize individuals who meet the standardized requirements.
The ChPP credential is currently scheduled to be introduced in the 2nd half of 2006 and further details surrounding the requirements will be made available closer to this time.
